The association of MHC with autoimmune diseases: Understanding the pathogenesis of autoimmune diabetes

Clinical Immunology and Immunopathology

Volumn 86, Issue 1, 1998, Pages 3-10

  Ridgway, William M ^a   Fathman, C Garrison ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; MHC; NOD mice; TCR avidity; Thymic selection

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DISEASE; CELL SELECTION; DISEASE SIMULATION; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031984204     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4449     Document Type: Review

References (52)

1. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II-associated autoimmunity. Science. 240:1988;1003-1009.
2. Ridgway W. M., Fasso M., Lanctot A., Garvey C., Fathman C. G. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183:1996;1657-1662.
3. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 175:1972;273-279.
4. Benacerraf B. Role of MHC gene products in immune regulation. Science. 212:1981;1229-1238.
5. Sette A., Buus S., Colon S., Smith J. A., Miles C., Grey H. M. Structural characteristics of an antigen required for its interaction with la and recognition by T cells. Nature. 328:1987;395-399.
6. Babbitt B. P., Allen P. M., Matsueda G., Haber E., Unanue E. R. Binding of immunogenic peptides to la histocompatibility molecules. Nature. 317:1985;359-361.
7. Svejgaard A., Platz P., Ryder L. P. HLA and disease 1982 - A survey. Immunol. Rev. 70:1983;193-218.
8. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599-604.
9. Rose N. R. Pathogenic mechanisms in autoimmune diseases. Clin. Immunol. Immunopathol. 53:1989;S7-S16.
10. Ramsdell F., Fowlkes B. J. Clonal deletion versus clonal anergy: The role of the thymus in inducing self tolerance. Science. 248:1990;1342-1348.
11. Jameson S. C., Hogquist K. A., Bevan M. J. Positive selection of thymocytes. Annu. Rev. Immunol. 13:1995;93-126.
12. Nossal G. J. Negative selection of lymphocytes. Cell. 76:1994;229-239.
13. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 49:1987;273-280.
14. Nepom G. T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes. 39:1990;1153-1157.
15. Vaysburd M., Lock C., McDevitt H. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides. J. Exp. Med. 182:1995;897-902.
16. Makino S., Muraoka Y., Kishimoto Y., Hayashi Y. Genetic analysis for insulitis in NOD mice. Jikken Dobutsu. 34:1985;425-431.
17. Wicker L. S., Miller B. J., Coker L. Z., McNally S. E., Scott S., Mullen Y., Appel M. C. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J. Exp. Med. 165:1987;1639-1654.
18. Serreze D. V., Leiter E. H. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium. J. Immunol. 147:1991;1222-1229.
19. Wraith D. C., Smilek D. E., Mitchell D. J., Steinman L., McDevitt H. O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:1989;247-255.
20. Gaur A., Wiers B., Liu A., Rothbard J., Fathman C. G. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science. 258:1992;1491-1494.
21. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell. 85:1996;291-297.
22. Bergman B., Haskins K. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes. 43:1994;197-203.
23. Tisch R., Yang X. D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
24. Humphreys-Beher M. G., Hu Y., Nakagawa Y., Wang P. L., Purushotham K. R. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome. Adv. Exp. Med. Biol. 350:1994;631-636.
25. Krug J., Williams A. J., Beales P. E., Doniach I., Gale E. A., Pozzilli P. Parathyroiditis in the non-obese diabetic mouse - A new finding. J. Endocrinol. 131:1991;193-196.
26. Baxter A. G., Horsfall A. C., Healey D., Ozegbe P., Day S., Williams D. G., Cooke A. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 83:1994;227-231.
27. Betterle C., Volpato M., Greggio A. N., Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J. Pediatr. Endocrinol. Metab. 9:1996;113-123.
28. Gaur A., Ruberti G., Haspel R., Mayer J. P., Fathman C. G. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science. 259:1993;91-94.
29. Podolin P. L., Pressey A., DeLarato N. H., Fischer P. A., Peterson L. B., Wicker L. S. I-E+ nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178:1993;793-803.
30. Slattery R. M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T. E., Miller J. F. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 345:1990;724-726.
31. Slattery R. M., Miller J. F., Heath W. R., Charlton B. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 90:1993;10808-10810.
32. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E. R. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:1996;450-458.
33. Ashton-Rickardt P. G., Tonegawa S. A differential-avidity model for T-cell selection. Immunol. Today. 15:1994;362-366.
34. Ashton-Rickardt P. G., Bandeira A., Delaney J. R., Van Kaer L., Pircher H. P., Zinkernagel R. M., Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76:1994;651-663.
35. Kim D. T., Rothbard J. B., Bloom D. D., Fathman C. G. Quantitative analysis of T cell activation: Role of TCR/ligand density and TCR affinity. J. Immunol. 156:1996;2737-2742.
36. Deng H., Apple R., Clare-Salzler M., Trembleau S., Mathis D., Adorini L., Sercarz E. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1993;1675-1680.
37. Alam S. M., Travers P. J., Wung J. L., Nasholds W., Redpath S., Jameson S. C., Gascoigne N. R. T-cell-receptor affinity and thymocyte positive selection. Nature. 381:1996;616-620.
38. Little C. C. The Biology of the Laboratory Mouse. 1941;Dover, New York. p. 279-309.
39. Bach F. H., Widmer M. B., Bach M. L., Klein J. Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J. Exp. Med. 136:1972;1430-1444.
40. Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
41. Steinman L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
42. Dallman M., Fathman C. G. Type II collagen-reactive T cell clones from mice with collagen-induced arthritis. J. Immunol. 135:1985;1113-1118.
43. Bevan M. J., Hunig T. T cells respond preferentially to antigens that are similar to self H-2. Proc. Natl. Acad. Sci. USA. 78:1981;1843-1847.
44. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 50:1987;819-820.
45. Wicker L. S., Todd J. A., Peterson L. B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200.
46. Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell. 85:1996;311-318.
47. Lee M. S., Mueller R., Wicker L. S., Peterson L. B., Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:1996;2663-2668.
48. Laufer T. M., DeKoning J., Markowitz J. S., Lo D., Glimcher L. H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 383:1996;81-85.
49. Buckner J., Kwok W. W., Nepom B., Nepom G. T. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J. Immunol. 157:1996;4940-4945.
50. Hattori M., Buse J. B., Jackson R. A., Glimcher L., Dorf M. E., Minami M., Makino S., Moriwaki K., Kuzuya H., Imura H. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex. Science. 231:1986;733-735.
51. Liu G. Y., Fairchild P. J., Smith R. M., Prowle J. R., Kioussis D., Wraith D. C. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:1995;407-415.
52. Fairchild P. J., Wildgoose R., Atherton E., Webb S., Wraith D. C. An autoantigenic T cell epitope forms unstable complexes with class II MHC: A novel route for escape from tolerance induction. Int. Immunol. 5:1993;1151-1158.